Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PALIVIZUMAB Cause Insurance issue? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Insurance issue have been filed in association with PALIVIZUMAB (Synagis). This represents 0.1% of all adverse event reports for PALIVIZUMAB.

11
Reports of Insurance issue with PALIVIZUMAB
0.1%
of all PALIVIZUMAB reports
0
Deaths
8
Hospitalizations

How Dangerous Is Insurance issue From PALIVIZUMAB?

Of the 11 reports, 8 (72.7%) required hospitalization, and 1 (9.1%) were considered life-threatening.

Is Insurance issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does PALIVIZUMAB Cause?

Respiratory syncytial virus infection (1,692) Pyrexia (1,055) Death (856) Bronchiolitis (724) Cough (665) Pneumonia (657) Dyspnoea (466) Nasopharyngitis (462) Vomiting (445) Influenza (398)

What Other Drugs Cause Insurance issue?

CERTOLIZUMAB PEGOL (1,210) HUMAN IMMUNOGLOBULIN G (1,090) LISDEXAMFETAMINE DIMESYLATE (590) RIFAXIMIN (577) LENALIDOMIDE (376) ARIPIPRAZOLE (345) HUMAN C1-ESTERASE INHIBITOR (295) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (253) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (227) ETANERCEPT (220)

Which PALIVIZUMAB Alternatives Have Lower Insurance issue Risk?

PALIVIZUMAB vs PALONOSETRON PALIVIZUMAB vs PAMIDRONATE PALIVIZUMAB vs PAMIDRONIC ACID PALIVIZUMAB vs PANCRELIPASE PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE

Related Pages

PALIVIZUMAB Full Profile All Insurance issue Reports All Drugs Causing Insurance issue PALIVIZUMAB Demographics